Vietnam Active Pharmaceutical Ingredients Market Growth Rate
According to 6Wresearch internal databases and industry insights, the Vietnam Active Pharmaceutical Ingredients (API) Market is projected to grow at a CAGR of 8.76% during the forecast period 2026–2032.
Vietnam Active Pharmaceutical Ingredients Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth pattern of the Vietnam Active Pharmaceutical Ingredients Market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
The following table summarizes the historical and forecasted growth rates of the Vietnam Active Pharmaceutical Ingredients Market, along with the rationale behind each year’s performance.
| Year | Estimated Growth (%) | Market Rationale |
| 2022 | 5.9% | Recovery in pharmaceutical manufacturing and improved medicine demand following pandemic disruptions. |
| 2023 | 6.6% | Growing imports of raw materials and increasing domestic pharmaceutical production. |
| 2024 | 7.3% | Expansion of generic medicine manufacturing and higher healthcare investments. |
| 2025 | 8% | Increasing local API production supported by government localization initiatives. |
| 2026 | 8.4% | Rising investment in GMP-compliant manufacturing facilities. |
| 2027 | 8.7% | Growing demand for APIs used in chronic disease medications. |
| 2028 | 9% | Expansion of export-oriented pharmaceutical production. |
| 2029 | 9.4% | Improved manufacturing efficiency through automation and quality upgrades. |
| 2030 | 9.8% | Increasing partnerships with international pharmaceutical manufacturers. |
| 2031 | 9.9% | Expansion of high-value API manufacturing capabilities. |
| 2032 | 10.3% | Strong domestic demand and continued pharmaceutical industry modernization. |
Topics Covered in the Vietnam Active Pharmaceutical Ingredients Market Report
The Vietnam Active Pharmaceutical Ingredients Market Report provides a comprehensive assessment based on API Type, Application, and End Users. The study evaluates major market drivers, emerging opportunities, competitive developments, regulatory landscape, technological advancements, investment prospects, and future industry outlook, enabling stakeholders to make strategic business decisions.
Vietnam Active Pharmaceutical Ingredients Market Highlights
| Report Name | Vietnam Active Pharmaceutical Ingredients Market |
| Forecast period | 2026-2032 |
| CAGR | 8.76% |
| Growing Sector | Generic Drugs Manufacturing |
Vietnam Active Pharmaceutical Ingredients Market Synopsis
The Vietnam Active Pharmaceutical Ingredients (API) Market is expected to grow during the forecast period, backed by growth in production of pharmaceuticals in the country, increased incidence of chronic conditions, and government programs aimed at promoting local manufacturing of APIs in order to decrease the level of dependence on imported API supplies.
In general, active pharmaceutical ingredients are biologically active components that produce medical effects and constitute the foundation of pharmaceutical products. Vietnam will be improving its pharmaceutical infrastructure by establishing new GMP certified manufacturing plants and implementing other measures. Growing production of generic medicines, increasing demand for specialty drugs, and expanding exports are further supporting long-term market growth.
Evaluation of Growth Drivers in Vietnam Active Pharmaceutical Ingredients Market (2026–2032)
Below mentioned are some major drivers and their influence on the market dynamics:
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Expansion of domestic pharmaceutical manufacturing | Pharmaceutical Companies | Supports higher local API production and reduces import dependency. |
| Increasing burden of chronic diseases | Cardiovascular APIs | Drives sustained demand for long-term therapeutic medications. |
| Government localization initiatives | Synthetic APIs | Encourages domestic API manufacturing investments. |
| Growth in generic drug production | Anti-infective APIs | Expands consumption of cost-effective pharmaceutical ingredients. |
| Technological modernization | Biological APIs | Improves manufacturing quality and regulatory compliance. |
Vietnam Active Pharmaceutical Ingredients Market is projected to grow at a CAGR of 8.76% during 2026–2032. This industry is expected to benefit from rising pharmaceutical manufacturing activities and increasing healthcare demand across both public and private sectors. Around 70% of the drugs used in Vietnam depend on foreign APIs, making it an area where the manufacturing industry could develop significantly. Generic medicines are currently responsible for about 60% of the drugs prescribed in Vietnam, and thus there is always growing demand for APIs manufactured using synthesis methods. The investment in GMP manufacturing facilities has increased consistently, and Vietnamese pharmaceuticals have been experiencing annual growth above 8%. Continuous adoption of advanced manufacturing technologies and quality management systems is expected to further improve production efficiency and global competitiveness.
Evaluation of Restraints in Vietnam Active Pharmaceutical Ingredients Market
Below are some major restraints and their influence on the market dynamics:
| Restraints | Primary Segment Affected | What This Means (Evidence) |
| Heavy dependence on imported raw materials | Synthetic APIs | Supply disruptions increase production risks and costs. |
| Strict international regulatory compliance | Pharmaceutical Companies | Requires continuous investment in quality systems. |
| Limited biologics manufacturing expertise | Biological APIs | Restricts expansion of advanced API production. |
| Environmental compliance requirements | CMOs | Higher operational expenditure for manufacturing facilities. |
| Price competition from regional manufacturers | Generic APIs | Places pressure on operating margins and profitability. |
Vietnam Active Pharmaceutical Ingredients Market Challenges
Despite strong growth prospects, the Vietnam API industry continues to face several structural challenges. More than 75% of pharmaceutical-grade raw materials are imported, exposing manufacturers to fluctuations in global supply chains and foreign exchange movements. Conformity with WHO-GMP and PIC/S requirements raises the cost of modernizing facilities to the tune of 15%-20%. Moreover, the production of biological APIs demands sophisticated process technologies as well as very specialized personnel, while the availability of pharmaceutical engineers is quite limited. The cost of energy and increased international competition is another factor affecting production costs.
Vietnam Active Pharmaceutical Ingredients Market Trends
Notable trends influencing the Vietnam Active Pharmaceutical Ingredients Market are listed below:
- Growing localization of API production – Domestic pharmaceutical companies are increasingly investing in API manufacturing capabilities to reduce dependence on imported active ingredients, strengthen supply chain security, and improve self-sufficiency within Vietnam’s pharmaceutical sector.
- Digital manufacturing implementation – Pharmaceutical manufacturers are adopting automation, advanced process control systems, and real-time quality monitoring technologies to enhance production efficiency, maintain consistent product quality, and meet global regulatory requirements.
- Development of export-certified manufacturing factories – Vietnamese companies producing APIs are investing in upgrading their factories and gaining certifications from international organizations like WHO-GMP, EU-GMP, etc.
Investment Opportunities in the Vietnam Active Pharmaceutical Ingredients Market
Major investment opportunities in the Vietnam Active Pharmaceutical Ingredients Market are presented below:
- Specialized APIs – The increased demand for advanced APIs used to produce therapies for cancers, cardiovascular diseases, and rare disease treatments is leading to investments in higher-margin APIs and market-growth opportunities.
- Analytical laboratories – Increasing regulatory pressures along with global compliance requirements are opening up opportunities for highly-specialized analytical laboratories, validation laboratories, and quality control labs that cater to API manufacturers.
- Environmentally sustainable pharmaceutical manufacturing – Investments in the production of environmentally sustainable APIs have become important as companies strive to lower their carbon footprints.
Top Players in Vietnam Active Pharmaceutical Ingredients Market
The following section outlines major companies operating in the Vietnam Active Pharmaceutical Ingredients Market:
1. Mekophar Chemical Pharmaceutical Joint Stock Company (Mekophar)
| Company Name | Mekophar Chemical Pharmaceutical Joint Stock Company (Mekophar) |
|---|---|
| Established Year | 1975 |
| Headquarters | Ho Chi Minh City, Vietnam |
| Official Website | Click Here |
Mekophar is one of the few Vietnamese companies directly involved in pharmaceutical chemical and API manufacturing.
2. Vietnam Medical Products Import-Export Joint Stock Company (Vimedimex VN)
| Company Name | Vietnam Medical Products Import-Export Joint Stock Company (Vimedimex VN) |
|---|---|
| Established Year | 1985 |
| Headquarters | Hanoi, Vietnam |
| Official Website | Click Here |
Vimedimex VN is a major pharmaceutical import-export company involved in the supply and distribution of pharmaceutical raw materials, APIs, chemicals, and healthcare products.
3. API Vietnam Co., Ltd.
| Company Name | API Vietnam Co., Ltd. |
|---|---|
| Established Year | 2000s |
| Headquarters | Hanoi, Vietnam |
| Official Website | Click Here |
API Vietnam specializes in the import, distribution, and trading of active pharmaceutical ingredients, excipients, fine chemicals, and pharmaceutical raw materials.
4. Central Pharmaceutical Joint Stock Company No. 1 (CPC1)
| Company Name | Central Pharmaceutical Joint Stock Company No. 1 (CPC1) |
|---|---|
| Established Year | 1975 |
| Headquarters | Hanoi, Vietnam |
| Official Website | Click Here |
CPC1 is a leading pharmaceutical distribution and import-export company involved in pharmaceutical raw materials, APIs, medical products, and related supplies.
5. Domesco Medical Import Export Joint Stock Corporation (DMC)
| Company Name | Domesco Medical Import Export Joint Stock Corporation (DMC) |
|---|---|
| Established Year | 1985 |
| Headquarters | Dong Thap, Vietnam |
| Official Website | Click Here |
Domesco is one of Vietnam’s established pharmaceutical manufacturers with strong capabilities in generic medicines and pharmaceutical production.
Government Initiatives being implemented in the Vietnam Active Pharmaceutical Ingredients Market
The Vietnamese government is working on making the country more self-sufficient in the pharmaceutical sector by means of the National Strategy for Pharmaceutical Industry Development to 2030 with Vision to 2045, which emphasizes the development of domestic production of APIs and investments in the construction of modern pharmaceutical facilities. At the same time, the Ministry of Health of Vietnam keeps encouraging WHO-GMP certification, and preference investment policies are used for high-tech pharmaceutical projects to establish new production facilities.
Future Insights of the Vietnam Active Pharmaceutical Ingredients Market
The Vietnam Active Pharmaceutical Ingredients Market is expected to witness sustained expansion as domestic pharmaceutical manufacturers continue investing in modern production technologies and international quality standards. APIs of biological origin will see a marked surge driven by biosimilar development and specialty drugs. Automation of the manufacturing process can help enhance efficiencies by almost 22%, and digital quality management systems can help minimize production errors by around 30%. As Vietnam expands pharmaceutical exports and strengthens local API manufacturing capabilities, the country is expected to become an increasingly competitive pharmaceutical production hub within Southeast Asia.
Market Segmentation Analysis
This report presents a detailed analysis of the market segments along with their leading categories.
By API Type – Synthetic APIs Account for the Largest Market Share while Biological APIs Record the Fastest Growth
According to Sumit Sagar, Senior Research Analyst, 6Wresearch, Synthetic APIs dominated the Vietnam Active Pharmaceutical Ingredients Market with an estimated share of 74.60% in 2025, primarily due to their extensive use in generic medicines, mature manufacturing technologies, lower production costs, and strong demand across cardiovascular, anti-infective, and metabolic disorder treatments. Meanwhile, Biological APIs are expected to witness the highest CAGR of 11.48% during 2026–2032, driven by increasing biologics development and rising investment in advanced pharmaceutical production facilities.
By Application – Anti-infective APIs Lead the Market while Oncology APIs Register the Highest Growth
The market share of Anti-infective APIs accounted for about 31.80% in 2025 due to the mass production of antibiotics, high demands for infection-related treatments, and continual production of generic drugs. The oncology APIs will grow at a rate of 10.92% between 2026 and 2032 owing to increased prevalence of cancer, advanced therapy development, and investments in specialty drug manufacturing.
By End Users – Pharmaceutical Companies Dominate the Market while CMOs Grow at the Fastest Pace
Pharmaceutical Companies held the leading 67.40% market share in 2025, owing to large-scale medicine production, expanding generic drug portfolios, and continuous procurement of pharmaceutical ingredients. The growth rate is anticipated to be the highest for Contract Manufacturing Organizations at a CAGR of 10.31%, owing to rising pharmaceutical outsourcing, rising globalization, and rising need for low-cost manufacturing processes.
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
Key Attractiveness of the Report:
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year: 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- Vietnam Active Pharmaceutical Ingredients Market Outlook
- Market Size of Vietnam Active Pharmaceutical Ingredients Market, 2025
- Forecast of Vietnam Active Pharmaceutical Ingredients Market, 2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Revenues & Volume for the Period 2022-2032
- Vietnam Active Pharmaceutical Ingredients Market Trend Evolution
- Vietnam Active Pharmaceutical Ingredients Market Drivers and Challenges
- Vietnam Active Pharmaceutical Ingredients Price Trends
- Vietnam Active Pharmaceutical Ingredients Porter's Five Forces
- Vietnam Active Pharmaceutical Ingredients Industry Life Cycle
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By API Type for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By Synthetic for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By Biological for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By Plant Extracts for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By Application for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By Anti-infective for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By Cardiovascular for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By Neurological for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By Metabolic Disorder for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By Respiratory for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By Oncology for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By End Users for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By CROs for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By CMOs for the Period 2022-2032
- Historical Data and Forecast of Vietnam Active Pharmaceutical Ingredients Market Revenues & Volume By Pharmaceutical for the Period 2022-2032
- Vietnam Active Pharmaceutical Ingredients Import Export Trade Statistics
- Market Opportunity Assessment By API Type
- Market Opportunity Assessment By Application
- Market Opportunity Assessment By End Users
- Vietnam Active Pharmaceutical Ingredients Top Companies Market Share
- Vietnam Active Pharmaceutical Ingredients Competitive Benchmarking By Technical and Operational Parameters
- Vietnam Active Pharmaceutical Ingredients Company Profiles
- Vietnam Active Pharmaceutical Ingredients Key Strategic Recommendations
Market Covered
The report offers an extensive study of the following market segments:
By API Type
- Synthetic
- Biological
- Plant Extracts
By Application
- Anti-infective
- Cardiovascular
- Neurological
- Metabolic Disorder
- Respiratory
- Oncology
By End Users
- CROs
- CMOs
- Pharmaceutical
